CHESTPress ReleasesWorld Bronchiectasis Day 2023

World Bronchiectasis Day 2023

On World Bronchiectasis Day, members of the Forum of International Respiratory Societies spotlight a lesser-known lung disease.

Glenview, IL – In support of the second annual World Bronchiectasis Day, July 1, the Forum of International Respiratory Societies (FIRS), of which the American College of Chest Physicians (CHEST) is a founding member, is joining the COPD Foundation and several global organizations to raise global awareness, share knowledge and discuss ways to reduce the burden of bronchiectasis for patients and their families worldwide.

A lesser-known chronic lung disease, bronchiectasis affects hundreds of thousands of children and adults worldwide. Individuals living with bronchiectasis experience recurring lung infections due to enlarged and scarred airways which make it difficult to clear mucus properly. Symptoms include frequent coughing (often with thick, discolored mucus), sputum production, breathlessness, repeat chest infections, increased tiredness, unexplained fever, chills, sweats, weight loss and chest pain.

Although there is currently no cure, detecting and treating bronchiectasis early can improve quality of life and long-term health.

"World Bronchiectasis Day was started with the intention of raising the profile of bronchiectasis to aid clinicians and patients in more readily recognizing its signs and symptoms,” said Jean Wright, MD, MBA, CEO of the COPD Foundation and World Bronchiectasis Day founding partner. “I am encouraged by the success of the first global educational campaign, but there is more to be done. Often misdiagnosed as pneumonia, bronchiectasis worsens over time. An accurate diagnosis is needed to begin treatments to effectively manage the disease.”

The inaugural World Bronchiectasis Day, July 1, 2022, raised awareness for bronchiectasis by sharing resources, including:

“CHEST is proud to support the second annual World Bronchiectasis Day,” says Doreen Addrizzo-Harris, MD, FCCP, President of the American College of Chest Physicians. “Campaigns such as this one incite a global conversation and raise recognition. Through increased awareness, we can do our part to support those living with bronchiectasis and their families worldwide.”

The sixth annual World Bronchiectasis & NTM Conference will take place in New York City on July 18 to 20. This CME-accredited, in-person and livestreaming course will feature the most up-to-date education in bronchiectasis and nontuberculous mycobacterial (NTM) infections, including original research presentations and more. Learn more, and register to attend the conference.

About World Bronchiectasis Day
World Bronchiectasis Day, recognized annually on July 1, aims to raise global awareness of bronchiectasis and help those with the disease and others yet to be diagnosed through education, advocacy and a global conversation focused on reducing the burden of bronchiectasis for patients and their families worldwide. To learn more about bronchiectasis and to support the annual World Bronchiectasis Day, visit

About the American College of Chest Physicians
The American College of Chest Physicians® (CHEST) is the global leader in the prevention, diagnosis and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST®, visit

About the Forum of International Respiratory Societies
The Forum of International Respiratory Societies (FIRS) is an organisation comprised of the world's leading international respiratory societies working together to improve lung health globally. The goal of FIRS is to unify and enhance efforts to improve lung health through the combined work of its more than 70,000 members globally.

FIRS comprises the American College of Chest Physicians (CHEST), American Thoracic Society (ATS), the Asian Pacific Society of Respirology (APSR), Asociación Latinoamericana de Tórax (ALAT), European Respiratory Society (ERS), International Union Against Tuberculosis and Lung Disease (The Union), Pan African Thoracic Society (PATS), the Global Initiative for Asthma (GINA) and the Global Initiative for Chronic Obstructive Lung Disease (GOLD).